Paid Clinical Trials and Focus Groups by Location |
|
|
|
Condition: HIV Infections
Interventions: Drug: darunavir tablets; Drug: ritonavir capsule
Sponsors: Tibotec Pharmaceuticals, Ireland; Tibotec Pharmaceuticals
Recruiting - verified February 2010
Condition: Human Immunodeficiency Virus
Interventions: Drug: Maraviroc along with an optimized background antiretroviral drug regimen; Drug: Optimized background antiretroviral drug regimen without maraviroc
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Coronary Heart Disease
Interventions: Drug: dalcetrapib; Drug: Placebo; Drug: Evidence-based medical care for Acute Coronary Syndrome
Sponsor: Hoffmann-La Roche
Recruiting - verified March 2010
Condition: Myocardial Infarction
Interventions: Drug: tenecteplase; Drug: enoxaparin; Drug: clopidogrel; Procedure: catheterisation; Procedure: primary PCI
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide (HMR1726); Drug: Placebo
Sponsor: Sanofi-Aventis
Recruiting - verified March 2010
Condition: Breast Cancer
Interventions: Biological: Trastuzumab; Drug: Lapatinib
Sponsor: GlaxoSmithKline
Recruiting - verified March 2010
Condition: Breast Cancer
Interventions: Drug: bevacizumab [Avastin]; Drug: Herceptin; Drug: Docetaxel
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Epilepsy, Partial
Interventions: Drug: Pregabalin; Drug: Lamotrigine
Sponsor: Pfizer
Recruiting - verified March 2010